Dynamic contrast-enhanced MR imaging kinetic parameters and molecular weight of dendritic contrast agents in tumor angiogenesis in mice.
about
Design of ProCAs (protein-based Gd(3+) MRI contrast agents) with high dose efficiency and capability for molecular imaging of cancer biomarkersMeasurements of tumor vascular leakiness using DCE in brain tumors: clinical applications.Application of a biodegradable macromolecular contrast agent in dynamic contrast-enhanced MRI for assessing the efficacy of indocyanine green-enhanced photothermal cancer therapy.Tumor characterization with dynamic contrast enhanced magnetic resonance imaging and biodegradable macromolecular contrast agents in miceA new ex vivo method to evaluate the performance of candidate MRI contrast agents: a proof-of-concept study.Noninvasive evaluation of antiangiogenic effect in a mouse tumor model by DCE-MRI with Gd-DTPA cystamine copolymers.Accounting for pharmacokinetic differences in dual-tracer receptor density imaging.In vivo imaging of tumor physiological, metabolic, and redox changes in response to the anti-angiogenic agent sunitinib: longitudinal assessment to identify transient vascular renormalization.Hyperpolarized (13)C spectroscopy detects early changes in tumor vasculature and metabolism after VEGF neutralization.Towards endometriosis diagnosis by gadofosveset-trisodium enhanced magnetic resonance imaging.Pixel-based absorption correction for dual-tracer fluorescence imaging of receptor binding potential.Longitudinal imaging studies of tumor microenvironment in mice treated with the mTOR inhibitor rapamycin.Paramagnetic liposomes for molecular MRI and MRI-guided drug delivery.Validation of dynamic contrast-enhanced magnetic resonance imaging-derived vascular permeability measurements using quantitative autoradiography in the RG2 rat brain tumor model.The role of dynamic contrast-enhanced MRI in cancer diagnosis and treatment.Magnetic and fluorescent nanoparticles for multimodality imaging.Polydisulfide Gd(III) chelates as biodegradable macromolecular magnetic resonance imaging contrast agents.Dynamic contrast-enhanced MRI for monitoring antiangiogenic treatment: determination of accurate and reliable perfusion parameters in a longitudinal study of a mouse xenograft model.Characterization of tumor angiogenesis with dynamic contrast-enhanced MRI and biodegradable macromolecular contrast agents in mice.Polydisulfide Based Biodegradable Macromolecular Magnetic Resonance Imaging Contrast Agents.Difference in the intratumoral distributions of extracellular-fluid and intravascular MR contrast agents in glioblastoma growth.Generalized paired-agent kinetic model for in vivo quantification of cancer cell-surface receptors under receptor saturation conditions.Assessment of the interstitial fluid pressure of tumors by dynamic contrast-enhanced magnetic resonance imaging with contrast agents of different molecular weights.Tumor endothelial marker imaging in melanomas using dual-tracer fluorescence molecular imaging.Assessment of neovascular permeability in a pancreatic tumor model using dynamic contrast-enhanced (DCE) MRI with contrast agents of different molecular weights.Evaluation of neovessels in atherosclerotic plaques of rabbits using an albumin-binding intravascular contrast agent and MRI.A novel approach to tracer-kinetic modeling for (macromolecular) dynamic contrast-enhanced MRI.Use of permeability surface area-product to differentiate intracranial tumours from abscess.Effects of magnetically labeled exogenous endothelial progenitor cells on cerebral blood perfusion and microvasculature alterations after traumatic brain injury in rat model.Dynamic contrast-enhanced MRI in mouse tumors at 11.7 T: comparison of three contrast agents with different molecular weights to assess the early effects of combretastatin A4.Vascular endothelial growth factor antisense oligonucleotides inhibit leptomeningeal metastasis in vivo.Investigation of the influence of sampling schemes on quantitative dynamic fluorescence imaging.
P2860
Q28235682-85293DDD-5BD3-4197-9935-0FF8037AA0BDQ30653828-7BD45B98-77E8-4B12-8254-0A600383F2FEQ33486630-5AAFAB47-A747-49B2-B3E0-45354CA595ACQ33584677-3A12AD37-9BE5-4715-9758-48CD60E0C593Q33614436-F96CE851-8F21-4B94-BCA0-BD3641932029Q33625077-6AD1F741-6534-4583-ACA0-1F47E6E2B8C4Q33688285-19A4796D-3D4B-44D8-AB1F-A10CFE600FD8Q34081980-41727A79-A525-4D26-885A-95FC0E5EF0D1Q34120237-BE04331F-F3C8-4638-8D8B-7A68B38E1F1CQ34211802-B4A2FE04-99C1-4E79-BC62-4CB1589695DFQ34387497-EF20B4D3-05A4-4220-98A5-3ECE98CCBAE1Q34490050-F0F14FC2-2A24-4B63-9F13-6452E2373508Q34736942-FD8A153C-6579-4D71-A7C6-731C8081E246Q35925126-4F0FDA6F-1E7D-44FF-8E97-ABD0D7C22045Q36457747-43D9C2E6-3748-4841-9666-7D9F8C329167Q36918024-53BA2D59-1400-4302-AE5B-E2D4044429E7Q36920307-B96E6A41-D7E2-4D99-AF19-625711198022Q37050403-5A5FAC8A-3567-404D-ACE7-5764EF29FC93Q37113814-A5AFDE0B-FFE4-4922-B670-49C14E6143A0Q37844434-E2552450-1E11-4FCB-AB7D-157F4A258EE8Q38376846-011B9EB2-25D5-4DE9-9F3A-731F420E3657Q39083974-8C707DDE-3837-4C94-9BB1-BB06C236FC25Q39249492-7B1DA26A-CD70-4AFE-A0C5-26C539D2E443Q39444594-3F5D0CBF-E5A3-4195-969C-FBE9D72FF1DAQ39543749-CACA6335-5DB6-48EB-A022-9D3326260519Q40120520-3858D051-8580-4F18-BC61-036E2B6363AEQ41110202-F850A2E0-C291-4AEB-9F6A-0514AE179864Q41899940-47CE68F2-B0BA-4E72-BBD9-25EFA06EEC15Q46435349-6C1768D9-B559-494E-B99B-F7786257BFD3Q52654441-D88A0EF1-B5E1-47C5-8A00-A6D6346BC77DQ53293284-5A71F437-A33D-4BC1-A444-D2DA090333CFQ54940302-7C0B86C7-9C30-4745-AC3D-09EC39B44026
P2860
Dynamic contrast-enhanced MR imaging kinetic parameters and molecular weight of dendritic contrast agents in tumor angiogenesis in mice.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Dynamic contrast-enhanced MR i ...... in tumor angiogenesis in mice.
@ast
Dynamic contrast-enhanced MR i ...... in tumor angiogenesis in mice.
@en
type
label
Dynamic contrast-enhanced MR i ...... in tumor angiogenesis in mice.
@ast
Dynamic contrast-enhanced MR i ...... in tumor angiogenesis in mice.
@en
prefLabel
Dynamic contrast-enhanced MR i ...... in tumor angiogenesis in mice.
@ast
Dynamic contrast-enhanced MR i ...... in tumor angiogenesis in mice.
@en
P2093
P1433
P1476
Dynamic contrast-enhanced MR i ...... in tumor angiogenesis in mice
@en
P2093
Arjan W Griffioen
Jos M A van Engelshoven
Marcel H P van Genderen
Quido G de Lussanet
Regina G H Beets-Tan
Sander Langereis
P356
10.1148/RADIOL.2351040411
P407
P577
2005-02-24T00:00:00Z